Leflunomide inhibition of BK virus replication in renal tubular epithelial cells

Journal of Virology

Volumn 84, Issue 4, 2010, Pages 2150-2156

  Bernhoff, Eva ^a,b   Tylden, Garth D ^a   Kjerpeseth, Lars J ^a   Gutteberg, Tore J ^a,b   Hirsch, Hans H ^c,d   Rinaldo, Christine H ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b Department of Microbiology and Virology   (Norway)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LEFLUNOMIDE; PYRIMIDINE; TERIFLUNOMIDE; URIDINE;

ANTIVIRAL ACTIVITY; ARTICLE; BK VIRUS; CONTROLLED STUDY; CYTOSTASIS; EPITHELIUM CELL; HOST CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; KIDNEY INFECTION; KIDNEY TUBULE EPITHELIUM; LIFE CYCLE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRION; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS INFECTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ANILINE COMPOUNDS; ANTIVIRAL AGENTS; BK VIRUS; CELLS, CULTURED; DNA REPLICATION; EPITHELIAL CELLS; HUMANS; HYDROXYBUTYRATES; ISOXAZOLES; KIDNEY TUBULES; MICROSCOPY, ELECTRON, TRANSMISSION; VIRAL LOAD; VIRAL STRUCTURAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

BK POLYOMAVIRUS; POLYOMAVIRUS;

EID: 75449107430     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01737-09     Document Type: Article

References (47)

1. Awdishu, L., E. Sonbol, A. Feist, F. Lin, O. Alemi, R. Huang, and R. Pharmacy. 2009. Leflunomide delays recovery in kidney transplant recipients with BK viremia. American Transplant Congress 2009, abstr. L 503.
2. Bansal, S., M. S. Lucia, and A. Wiseman. 2008. A case of polyomavirusassociated nephropathy presenting late after transplantation. Nat. Clin. Pract. Nephrol. 4:283-287.
3. Basse, G., C. Mengelle, N. Kamar, J. Guitard, D. Ribes, L. Esposito, and L. Rostaing. 2007. Prospective evaluation of BK virus DNAemia in renal transplant patients and their transplant outcome. Transplant. Proc. 39:84-87.
4. Baumann, P., S. Mandl-Weber, A. Volkl, C. Adam, I. Bumeder, F. Oduncu, and R. Schmidmaier. 2009. Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells. Mol. Cancer Ther. 8:366-375.
5. Bernhoff, E., T. J. Gutteberg, K. Sandvik, H. H. Hirsch, and C. H. Rinaldo. 2008. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am. J. Transplant. 8:1413-1422.
6. Chang, C. Y., A. Gangji, K. Chorneyko, and A. Kapoor. 2005. Urological manifestations of BK polyomavirus in renal transplant recipients. Can. J. Urol. 12:2829-2836.
7. Cherwinski, H. M., D. McCarley, R. Schatzman, B. Devens, and J. T. Ransom. 1995. The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism. J. Pharmacol. Exp. Ther. 272:460-468.
8. Cole, C. N. 1996. Polyomavirinae: the viruses and their replication, p. 1997-2043. In B. N. Fields, D. M. Knipe, and P. H. Howley (ed.), Fields virology, vol. 2. Lippincott-Raven, New York, NY.
9. Crew, R. J., G. Markowitz, and J. Radhakrishnan. 2006. Therapeutic options in BK virus-associated interstitial nephritis. Kidney Int. 70:399-402.
10. Davis, J. P., G. A. Cain, W. J. Pitts, R. L. Magolda, and R. A. Copeland. 1996. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry 35:1270-1273.
11. Drachenberg, C. B., J. C. Papadimitriou, R. Wali, C. L. Cubitt, and E. Ramos. 2003. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am. J. Transplant. 3:1383-1392.
12. Duclos, A. J., V. Krishnamurthi, M. Lard, E. Poggio, M. Kleeman, C. Winans, R. Fatica, and S. Nurko. 2006. Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients. Transplant. Proc. 38:3666-3672.
13. Faguer, S., H. H. Hirsch, N. Kamar, C. Guilbeau-Frugier, D. Ribes, J. Guitard, L. Esposito, O. Cointault, A. Modesto, M. Lavit, C. Mengelle, and L. Rostaing. 2007. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl. Int. 20:962-969.
14. Farasati, N. A., R. Shapiro, A. Vats, and P. Randhawa. 2005. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 79:116-118.
15. Feng, H., X. Y. Li, J. R. Zheng, J. W. Gao, L. F. Xu, and M. Y. Tang. 2005. Inhibition of the nuclear factor-kappaB signaling pathway by leflunomide or triptolide also inhibits the anthralin-induced inflammatory response but does not affect keratinocyte growth inhibition. Biol. Pharm. Bull. 28:1597-1602.
16. Funk, G. A., R. Gosert, P. Comoli, F. Ginevri, and H. H. Hirsch. 2008. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am. J. Transplant. 8:2368-2377.
17. Grinde, B., M. Gayorfar, and C. H. Rinaldo. 2007. Impact of a polyomavirus (BKV) infection on mRNA expression in human endothelial cells. Virus Res. 123:86-94.
18. Hamilton, L. C., I. Vojnovic, and T. D. Warner. 1999. A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner. Br. J. Pharmacol. 127: 1589-1596.
19. Herrmann, M. L., R. Schleyerbach, and B. J. Kirschbaum. 2000. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Immunopharmacology 47:273-289.
20. Hey, A. W., J. I. Johnsen, B. Johansen, and T. Traavik. 1994. A two fusion partner system for raising antibodies against small immunogens expressed in bacteria. J. Immunol. Methods 173:149-156.
21. Hirsch, H. H., D. C. Brennan, C. B. Drachenberg, F. Ginevri, J. Gordon, A. P. Limaye, M. J. Mihatsch, V. Nickeleit, E. Ramos, P. Randhawa, R. Shapiro, J. Steiger, M. Suthanthiran, and J. Trofe. 2005. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277-1286.
22. Hirsch, H. H., and J. Steiger. 2003. Polyomavirus BK. Lancet Infect. Dis. 3:611-623.
23. Jiang, M., J. R. Abend, S. F. Johnson, and M. J. Imperiale. 2009. The role of polyomaviruses in human disease. Virology 384:266-273.
24. Josephson, M. A., D. Gillen, B. Javaid, P. Kadambi, S. Meehan, P. Foster, R. Harland, R. J. Thistlethwaite, M. Garfinkel, W. Atwood, J. Jordan, M. Sadhu, M. J. Millis, and J. Williams. 2006. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 81:704-710.
25. Knight, D. A., A. Q. Hejmanowski, J. E. Dierksheide, J. W. Williams, A. S. Chong, and W. J. Waldman. 2001. Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. Transplantation 71:170-174.
26. Leca, N., K. A. Muczynski, J. A. Jefferson, I. H. de Boer, J. Kowalewska, E. A. Kendrick, R. Pichler, and C. L. Davis. 2008. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin. J. Am. Soc. Nephrol. 3:829-835.
27. Leuenberger, D., P. A. Andresen, R. Gosert, S. Binggeli, E. H. Strom, S. Bodaghi, C. H. Rinaldo, and H. H. Hirsch. 2007. Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed, but immunologically ignored. Clin. Vaccine Immunol. 14:959-968.
28. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
29. Mattar, T., K. Kochhar, R. Bartlett, E. G. Bremer, and A. Finnegan. 1993. Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide. FEBS Lett. 334:161-164.
30. Mazzucco, G., C. Costa, M. Bergallo, G. P. Segoloni, and G. Monga. 2008. Severe crescentic BK virus nephropathy with favourable outcome in a transplanted patient treated with Leflunomide. Clin. Nephrol. 70:163-167.
31. Nair, R. V., W. Cao, and R. E. Morris. 1995. Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine. Immunol. Lett. 48:77-80.
32. Ng, J., O. Koechlin, M. Ramalho, D. Raman, and N. Krauzewicz. 2007. Extracellular self-assembly of virus-like particles from secreted recombinant polyoma virus major coat protein. Protein Eng. Des. Sel. 20:591-598.
33. Nilsson, J., N. Miyazaki, L. Xing, B. Wu, L. Hammar, T. C. Li, N. Takeda, T. Miyamura, and R. H. Cheng. 2005. Structure and assembly of a T=1 virus-like particle in BK polyomavirus. J. Virol. 79:5337-5345.
34. Ott, U., T. Steiner, M. Busch, J. Gerth, and G. Wolf. 2008. A single-center experience with BK virus nephropathy. Clin. Nephrol. 69:244-250.
35. Randhawa, P., R. Shapiro, and A. Vats. 2005. Quantitation of DNA of polyomaviruses BK and JC in human kidneys. J. Infect. Dis. 192:504-509.
36. Randhawa, P. S., A. Vats, D. Zygmunt, P. Swalsky, V. Scantlebury, R. Shapiro, and S. Finkelstein. 2002. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 74: 485-488.
37. Rinaldo, C. H., and H. H. Hirsch. 2007. Antivirals for the treatment of polyomavirus BK replication. Expert Rev. Anti Infect. Ther. 5:105-115.
38. Schlapfer, E., M. Fischer, P. Ott, and R. F. Speck. 2003. Anti-HIV-1 activity of leflunomide: a comparison with mycophenolic acid and hydroxyurea. AIDS 17:1613-1620.
39. Sessa, A., A. Esposito, A. Giliberti, M. Bergallo, C. Costa, R. Rossano, E. Lettieri, and M. Capuano. 2008. BKV reactivation in renal transplant recipients: diagnostic and therapeutic strategy-case reports. Transplant. Proc. 40:2055-2058.
40. Teschner, S., P. Gerke, M. Geyer, J. Wilpert, B. Krumme, and G. Walz. 2008. Leflunomide therapy for polyomavirus-induced allograft nephropathy. American Transplant Congress 2008, abstr. L 1063.
41. Teschner, S., M. Geyer, J. Wilpert, E. Schwertfeger, T. Schenk, G. Walz, and J. Donauer. 2006. Remission of polyomavirus-induced graft nephropathy treated with low-dose leflunomide. Nephrol. Dial. Transplant. 21:2039-2040.
42. Tsukamoto, H., M. A. Kawano, T. Inoue, T. Enomoto, R. U. Takahashi, N. Yokoyama, N. Yamamoto, T. Imai, K. Kataoka, Y. Yamaguchi, and H. Handa. 2007. Evidence that SV40 VP1-DNA interactions contribute to the assembly of 40-nm spherical viral particles. Genes Cells 12:1267-1279.
43. Vogetseder, A., T. Palan, D. Bacic, B. Kaissling, and M. Le Hir. 2007. Proximal tubular epithelial cells are generated by division of differentiated cells in the healthy kidney. Am. J. Physiol. Cell Physiol. 292:C807-C813.
44. Waldman, W. J., D. A. Knight, L. Blinder, J. Shen, N. S. Lurain, D. M. Miller, D. D. Sedmak, J. W. Williams, and A. S. Chong. 1999. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 42:412-418.
45. Williams, J. W., B. Javaid, P. V. Kadambi, D. Gillen, R. Harland, J. R. Thistlewaite, M. Garfinkel, P. Foster, W. Atwood, J. M. Millis, S. M. Meehan, and M. A. Josephson. 2005. Leflunomide for polyomavirus type BK nephropathy. N. Engl. J. Med. 352:1157-1158.
46. Xu, X., J. W. Williams, E. G. Bremer, A. Finnegan, and A. S. Chong. 1995. Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J. Biol. Chem. 270:12398- 12403.
47. Zavos, G., M. Gazouli, E. Psimenou, I. Papaconstantinou, J. Bokos, J. Boletis, A. Zografidis, and A. Kostakis. 2004. Polyomavirus BK infection in Greek renal transplant recipients. Transplant. Proc. 36:1413-1414.